CD79A and inflammatory bowel disease: The enriched KEGG pathways were as follows: “cytokine–cytokine receptor interaction”, “chemokine signaling pathway”, “intestinal immune network for IgA production”, and “inflammatory bowel disease”, indicating the potential role of CCL22 in gastrointestinal diseases (Figure 4B).